Royalty Pharma plc (FRA:RPD)
Germany
· Delayed Price · Currency is EUR 30.07
0.00 (0.00%)
Last updated: Jun 23, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2020 |
| Revenue from Intangible Royalty Assets | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Revenue from Intangible Royalty Assets Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Royalty Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Royalty Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cystic Fibrosis Franchise | 803.89M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cystic Fibrosis Franchise Growth | -7.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tysabri | 123.42M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tysabri Growth | -20.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imbruvica | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imbruvica Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Xtandi | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Xtandi Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Promacta | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Promacta Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Products | 575.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Products Growth | 8.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tremfya | 148.98M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tremfya Growth | 1.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trelegy | 148.07M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trelegy Growth | 13.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Evrysdi | 221.21M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Evrysdi Growth | 63.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2020 |
| Portfolio Receipts | 2.92B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Portfolio Receipts Growth | 17.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|